PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29794736
OWN - NLM
STAT- MEDLINE
DCOM- 20180612
LR  - 20180612
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 21
DP  - 2018 May
TI  - Parotid gland metastasis from carcinoma of the breast detected by PET/CT: Case
      report and review.
PG  - e10616
LID - 10.1097/MD.0000000000010616 [doi]
AB  - RATIONALE: The parotid gland is an unusual site for metastatic disease from
      breast cancer, and it usually has a poor prognosis. PATIENT CONCERNS: A
      36-year-old woman presented to our department with a swelling in her left parotid
      gland. The patient did not receive any other treatment after breast conserving
      surgery. DIAGNOSES: Multifocal metastases in the bones, lymph nodes, left parotid
      and contralateral mammary gland were proved by PET/CT. INTERVENTIONS: Eight
      cycles of first-line rescue chemotherapy, combining with zoledronic acid in
      treatment of bone metastasis, followed by the combination of endocrine therapy
      and ovarian function suppression after chemotherapy. OUTCOMES: The patient
      obtained clinical complete response in the metastasis tumor of parotid gland,
      lymph nodes, and bones. LESSONS: It is necessary for patient to receive
      comprehensive treatment after receiving surgery. Through this case, we present
      the appropriate management of advanced breast cancer accompanying with the
      parotid gland metastasis. PET/CT is a useful method to diagnose and evaluate the 
      metastasis lesions.
FAU - Cao, Xiao-Shan
AU  - Cao XS
AD  - Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University.
FAU - Cong, Bin-Bin
AU  - Cong BB
AD  - Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University.
AD  - School of Medicine and Life Sciences, University of Jinan and Shandong Academy of
      Medical Sciences, Jinan, Shandong, China.
FAU - Yu, Zhi-Yong
AU  - Yu ZY
AD  - Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Diphosphonates)
RN  - 0 (Imidazoles)
RN  - 6XC1PAD3KF (zoledronic acid)
SB  - AIM
SB  - IM
MH  - Adult
MH  - Antineoplastic Agents/therapeutic use
MH  - Breast Neoplasms/*pathology/therapy
MH  - Combined Modality Therapy/methods
MH  - Diphosphonates/therapeutic use
MH  - Female
MH  - Humans
MH  - Imidazoles/therapeutic use
MH  - Mastectomy, Segmental/methods
MH  - Parotid Gland/*pathology
MH  - Parotid Neoplasms/diagnostic imaging/*secondary/therapy
MH  - Positron Emission Tomography Computed Tomography/methods
EDAT- 2018/05/26 06:00
MHDA- 2018/06/13 06:00
CRDT- 2018/05/26 06:00
PHST- 2018/05/26 06:00 [entrez]
PHST- 2018/05/26 06:00 [pubmed]
PHST- 2018/06/13 06:00 [medline]
AID - 10.1097/MD.0000000000010616 [doi]
AID - 00005792-201805250-00012 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2018 May;97(21):e10616. doi: 10.1097/MD.0000000000010616.